한글목차

세계 액체생검 시장 규모는 2024년 46억 달러로, 예측 기간 동안 CAGR는 23.3%로 추이하고, 2029년 말에는 131억 달러에 달할 것으로 예측됩니다.

북미 시장은 2024년 20억 달러로, 예측 기간 동안 CAGR 23.1%로 추이하고, 2029년 말에는 57억 달러에 달할 것으로 예측되고 있습니다. 유럽 시장은 2024년 13억 달러에 이르고, CAGR는 22.2%로 추이하고, 2029년 말에는 35억 달러에 이를 것으로 예측됩니다.

본 보고서에서는 세계의 액체생검 시장을 조사했으며, 시장 개요, 시장 영향요인 및 시장 기회의 분석, 법 규제 환경, 신기술 및 기술 개발의 동향, 시장 규모 추이와 예측, 각종 구분, 지역별 상세 분석, 경쟁 구도, 주요 기업 프로파일 등을 정리했습니다.

목차

제1장 주요 요약

• 시장 전망
• 조사 범위
• 시장 개요

제2장 시장 개요

• 개요
• 액체생검과 기존 생검
• 액체생검에서 사용되는 분석물
• 액체생검의 새로운 임상 응용

제3장 시장 역학

• 시장 역학
• 시장 성장 촉진요인
• 액체생검 워크플로우 기술의 진보
• 암 발생률 증가
• 암 조기 발견에 대한 의식 향상
• 조직 생검의 한계
• 시장 성장 억제요인
• 특정 액체생검의 감도 저하
• 시장 기회
• 정밀의료의 중요성 증가
• 중국 등 신흥국

제4장 신흥기술과 임상시험

• 액체생검용 나노 테크놀로지
• 액체생검의 미세 유체 기반 장치
• 액체생검 시장에서의 임상시험

제5장 시장 세분화 분석

• 시장 동향
• 세분화의 내역
• 세계의 액체생검 시장 : 용도별
• 비침습적 산전 검사(NIPT)
• 암
• 장기 이식
• 세계의 액체생검 시장 : 분석 목적별
• 조기 발견 및 스크리닝
• 감시
• 진단
• 치료 지침
• 세계의 액체생검 시장 : 바이오 마커 유형별
• 무세포 핵산
• 순환 종양 세포
• 기타
• 세계의 액체생검 시장 : 분석 플랫폼별
• 차세대 시퀀싱(NGS)
• 중합효소 연쇄반응(PCR)
• 기타
• 세계의 액체생검 시장 : 암 부위별
• 범암
• 대장암
• 유방암
• 폐암
• 방광암
• 전립선암
• 혈액암
• 부인과 암
• 기타
• 지리적 내역
• 세계의 액체생검 시장 :지역별
• 북미
• 유럽
• 아시아태평양
• 기타 지역

제6장 경쟁 정보

• 주요 기업의 랭킹
• 비교 분석

제7장 액체생검 시장에서의 지속가능성: ESG의 관점

• ESG: 소개
• 액체생검 업계에서의 ESG 실천
• 환경 성능
• 사회적 성능
• 거버넌스 퍼포먼스
• ESG 위험 평가
• BCC에 의한 총론

제8장 부록

• 조사 방법
• 약어
• 참고문헌
• 기업 프로파일
• BIO-RAD LABORATORIES INC.
• BIO-TECHNE
• DXCOVER LTD.
• EXACT SCIENCES CORP.
• F. HOFFMANN-LA ROCHE LTD.
• FREEENOME HOLDINGS INC.
• GUARDANT HEALTH
• ILLUMINA INC.
• MYRIAD GENETICS INC.
• NATERA INC.
• NEOGENOMICS LABORATORIES
• NOVIGENIX SA
• PERSONALIS INC.
• QIAGEN
• THERMO FISHER SCIENTIFIC INC.

영문목차

The global market for liquid biopsy is expected to grow from $4.6 billion in 2024 and is projected to reach $13.1 billion by the end of 2029, at a compound annual growth rate (CAGR) of 23.3% during the forecast period of 2024 to 2029.

The North American liquid biopsy market is expected to grow from $2.0 billion in 2024 and is projected to reach $5.7 billion by the end of 2029, at a CAGR of 23.1% during the forecast period of 2024 to 2029.

The European liquid biopsy market is expected to grow from $1.3 billion in 2024 and is projected to reach $3.5 billion by the end of 2029, at a CAGR of 22.2% during the forecast period of 2024 to 2029.

Report Scope

This report provides an in-depth analysis of the global market for liquid biopsy tools, services and diagnostics, including market estimations and trends, using 2023 as the base year and forecasting 2024 through 2029 with a compound annual growth rate (CAGR) projection. The report includes an overview of the industry structure and its competitive landscape. Leading market players' profiles, product offerings, financial information and recent market activities are provided. The report also assesses companies' business strategies and their effect in the face of the competitive environment. It details the global market based on application, purpose of analysis, biomarker type and platform. Regional analysis includes North America (U.S., Canada, Mexico), Europe (U.K., Germany, France, Spain, Italy, Rest of Europe), Asia-Pacific (China, India, Japan, and Rest of Asia-Pacific), and the Rest of the world (South America, and the Middle East and Africa).

Report Includes

• 65 data tables and 58 additional tables
• Analyses of the trends in the global market for liquid biopsy research tools, services and diagnostics, with market revenue data (sales figures) for 2022, estimates for 2023, forecasts for 2024, and projected CAGRs through 2029
• Estimates of the market size and revenue growth prospects, along with a market share analysis by application, purpose of analysis, biomarker type, analysis platform (technology type) and region
• Examination of conventional biopsy methods and liquid biopsy enabling technologies
• Discussion of large-scale research initiatives
• Facts and figures pertaining to key market dynamics, technology advances, regulations, and the impact of macroeconomic factors
• Insights derived from the Porter's Five Forces model, as well as global supply chain and PESTLE analyses
• Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, and the ESG scores and practices of leading companies
• Patent analysis, including key granted and published patents
• Analysis of the industry structure, including companies' market shares and rankings, strategic alliances, M&A activity and a venture funding outlook
• Profiles of leading companies, including Exact Sciences Corp., Natera Inc., Guardant Health, Roche, and NeoGenomics Laboratories

Table of Contents

Chapter 1 Executive Summary

• Market Outlook
• Scope of Report
• Market Summary

Chapter 2 Market Overview

• Overview
• Liquid Biopsy Versus Traditional Biopsy
• Analytes Used in Liquid Biopsy
• Emerging Clinical Applications of Liquid Biopsy

Chapter 3 Market Dynamics

• Market Dynamics
• Market Drivers
• Advances in Liquid Biopsy Workflow Technologies
• Increasing Incidence of Cancer
• Increasing Awareness of Early Cancer Detection
• Limitations of Tissue Biopsy
• Market Restraints
• Lower Sensitivity of Certain Liquid Biopsy Procedures
• Market Opportunities
• Growing Significance of Precision Medicine
• Emerging Economies such as China

Chapter 4 Emerging Technologies and Clinical Trials

• Nanotechnology in Liquid Biopsy
• Microfluidic-based Devices in Liquid Biopsy
• Clinical Trials in Liquid Biopsy Market

Chapter 5 Market Segmentation Analysis

• Market Trends
• Segmentation Breakdown
• Global Market for Liquid Biopsy by Application
• Non-invasive Prenatal Testing (NIPT)
• Cancer
• Organ Transplantation
• Global Market for Liquid Biopsy by Purpose of Analysis
• Early Detection/Screening
• Monitoring
• Diagnosis
• Therapy Guidance
• Global Market for Liquid Biopsy by Biomarker Type
• Cell-free Nucleic Acids
• Circulating Tumor Cells
• Other Biomarker Types
• Global Market for Liquid Biopsy by Analysis Platform
• Next-Generation Sequencing (NGS)
• Polymerase Chain Reaction (PCR)
• Other Analysis Platforms
• Global Market for Liquid Biopsy by Cancer Site
• Pan-Cancer
• Colorectal Cancer
• Breast Cancer
• Lung Cancer
• Bladder Cancer
• Prostate Cancer
• Hematologic Cancer
• Gynecologic Cancer
• Other Cancers
• Geographic Breakdown
• Global Market for Liquid Biopsy by Region
• North America
• Europe
• Asia-Pacific
• Rest of the World (RoW)

Chapter 6 Competitive Intelligence

• Ranking of Leading Players
• Comparative Analysis

Chapter 7 Sustainability in the Liquid Biopsy Market: ESG Perspective

• Introduction to ESG
• ESG Practices in the Liquid Biopsy Industry
• Environmental Performance
• Social Performance
• Governance Performance
• ESG Risk Ratings
• Concluding Remarks from BCC Research

Chapter 8 Appendix

• Methodology
• Abbreviations
• References
• Company Profiles
• BIO-RAD LABORATORIES INC.
• BIO-TECHNE
• DXCOVER LTD.
• EXACT SCIENCES CORP.
• F. HOFFMANN-LA ROCHE LTD.
• FREEENOME HOLDINGS INC.
• GUARDANT HEALTH
• ILLUMINA INC.
• MYRIAD GENETICS INC.
• NATERA INC.
• NEOGENOMICS LABORATORIES
• NOVIGENIX SA
• PERSONALIS INC.
• QIAGEN
• THERMO FISHER SCIENTIFIC INC.